Eligibility
Eligibility
Abbott's current cross-market materials describe Lingo for people 18 or older who are not using insulin. Confirm UK-specific suitability and device compatibility before buying.
A 14-day continuous glucose biosensor and companion app designed to show how food, movement, sleep, and stress relate to glucose patterns.
Who they are
Lingo is an Abbott-owned consumer product that pairs a 14-day continuous glucose biosensor with an app. The sensor streams interstitial glucose data each minute; the app connects those patterns to meals, activity, stress, and other logged events and turns them into trends, challenges, and a daily Lingo Count.
The practical details to understand before comparing the current offer.
Lingo says its glucose feedback shows users how to fuel their bodies to minimize spikes, curb cravings and feel more energised and focused for longer.
Lingo says seeing real-time glucose data can help users build habits that reduce body fat.
Cost + payment
Current UK plans
Two non-renewing plans and one auto-renewing subscription.
The plan price includes the listed sensors and app access. Confirm phone compatibility, delivery and current guarantee terms before purchase.
One biosensor · two weeks of app access · no automatic renewal
Two biosensors · four weeks of app access · no automatic renewal
Six biosensors · monthly shipments · auto-renewing 12-week term
The £59 and £99 plans do not auto-renew; the £289 option is a subscription.
These prices and terms are for the UK offer; do not apply U.S. pricing, clearance or eligibility language to a UK purchase.
Each plan combines an upper-arm biosensor with the Lingo app. The longer option changes the term and renewal model rather than the measurement.
Two non-renewing plans and one auto-renewing 12-week subscription.
Package
One biosensor and two weeks of app access; the current route does not auto-renew.
Availability: available
Link verified
Two non-renewing plans and one auto-renewing 12-week subscription.
Package
Two biosensors and four weeks of app access; the current route does not auto-renew.
Availability: available
Link verified
Two non-renewing plans and one auto-renewing 12-week subscription.
Subscription
Six biosensors shipped monthly with a 12-week term that auto-renews.
Review renewal, cancellation and first-purchase guarantee terms before checkout.
Availability: available
Link verified
For consumers
One biosensor · two weeks of app access · no automatic renewal
DevicePackage
For consumers
Two biosensors · four weeks of app access · no automatic renewal
DevicePackage
For consumers
Six biosensors · monthly shipments · auto-renewing 12-week term
Review renewal, cancellation and first-purchase guarantee terms before checkout.
DeviceSubscription
Start → result
Apply the sensor, pair it with a compatible phone, observe glucose patterns and use the app to test habits over the plan period.
Attach the biosensor to the back of the upper arm and pair it with a compatible phone.
Watch the glucose graph update and log food, activity, stress, and other events.
Use Lingo Count, trends, progress reports, and habit challenges to compare patterns over time.
What is measured
The biosensor measures glucose in interstitial fluid and the app organizes the data into trends, scores and experiments.
Biosensor + app
minute-by-minute interstitial glucose · up to 14 days per sensor · Bluetooth streaming · no charging
Choose a plan length based on how long you want to observe patterns; one sensor covers up to 14 days.
Biosensor + app
real-time glucose graph · Lingo Count · weekly trends · progress reports
Lingo Count and weekly trends summarize patterns in the app; they are not a clinician's interpretation.
Biosensor + app
food and activity logging · stress and sleep context · habit challenges · educational content
Use logs and challenges to compare food, activity, stress and sleep with your readings; do not use the app alone to make medical decisions.
Where + how to access
UK customers can buy directly from Lingo; plan terms and eligibility are market-specific.
What the evidence shows
Lingo is an Abbott product with regulatory and performance documentation. Evidence for routine CGM use among people without diabetes remains incomplete and should be separated from product usability.
Abbott's UK pages list three plan prices, up to 14 days per sensor, minute-by-minute app data, subscription terms and product support.
The FDA database confirms over-the-counter clearance for the U.S. Lingo system. Peer-reviewed reviews show that CGMs can reveal glucose patterns, but evidence of lasting health or behavior change in people without diabetes remains limited. Clearance does not validate every in-app coaching claim.
CGM can display glucose patterns, but expert and systematic reviews describe consumer use in people without diabetes as an emerging field with limited evidence for durable clinical benefit. Abbott's surveys and app metrics are company data, and FDA clearance of the U.S. system does not prove that Lingo prevents diabetes, causes weight loss, or improves long-term outcomes.
Abbott's current cross-market release describes Lingo for adults 18 or older who are not using insulin and says it is not intended to diagnose diseases, including diabetes. Users should not make medication, diet, or exercise changes solely from app readings, and people with an eating-disorder history should consult a healthcare professional. UK-specific suitability and phone compatibility still need checking before purchase.
Reporting + company history
News coverage provides outside context, while company announcements document launches and milestones.
Reporting covers regulatory clearance, launch and consumer experience. U.S. coverage does not establish the UK product's exact terms or classification.
Reuters
Independent reporting
Checked 29 Aug 2026
MedTech Dive
Trade reporting
Checked 29 Aug 2026
Reuters
Reporting
Checked 26 Aug 2026
CNBC
Reporting
Checked 26 Aug 2026
TechCrunch
Reporting
Checked 26 Aug 2026
The Verge
Reporting
Checked 26 Aug 2026
Good Housekeeping UK
Reporting
Checked 26 Aug 2026
Company announcements document launches and milestones; they do not independently establish health benefit.
Abbott
Company or partner release
Checked 29 Aug 2026
Decision guide
Eligibility
Abbott's current cross-market materials describe Lingo for people 18 or older who are not using insulin. Confirm UK-specific suitability and device compatibility before buying.
Evidence boundary
Consumer CGM data can be informative but is not a diagnosis. Individual sensors can disagree, interstitial readings differ from direct blood measurements, and interpretation for people without diabetes is still evolving.
Common questions
Transparency
Researched by Longevity.io
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint